Our Mission
Redefining Post-Surgical Healing
Jaycox & Co. is a preclinical-stage biotechnology company developing proprietary peptide compounds designed to accelerate and improve tissue repair following surgery. Our approach targets the fundamental biological mechanisms of healing — harnessing peptide signaling to promote faster, more complete recovery for patients undergoing orthopedic, general, and reconstructive surgical procedures.
Current post-surgical protocols rely on outdated approaches with limited efficacy. We believe peptide therapeutics represent a paradigm shift in surgical recovery — offering targeted, biological solutions that work with the body's own repair processes rather than masking symptoms. Our lead program, JXC-001, is being developed to address this critical unmet medical need.
